Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

10 hours ago 6

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026.

Tom Little | Reuters

Novo on Tuesday sai...